Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
Clinical trial NCT07340216 · COMPLETED
Trial details
- NCT number
- NCT07340216
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2026-04-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.